The effectiveness of semaglutida in preventing cardiovascular risks associated with obesity and diabetes. Acervo Médico [Internet]. 2025 Oct. 29 [cited 2026 Nov. 3];25:e21868. Available from: https://acervomais.com.br/medico/article/view/21868